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ABSTRACT 
 
Celiac Disease (CD) or Gluten Sensitive Enteropathy (GSE) is a life-long disorder. It is 
characterized by inflammation in the small intestine of genetically predisposed individuals 
caused by inappropriate immune response to gluten, a protein enriched in some of our 
common grains (wheat, rye and barley). The toxicity of gluten is manifested by the 
autoimmune action of T-lymphocytes on mucosal cells in the small intestine, disrupting its 
vital function of absorbing nutrients from the food. The disease affects predominantly 
children, but it can develop later in life as well. Untreated CD involves risk for major 
complications: Dermatitis herpetiformis (“the celiac disease of the skin”), nutritional 
deficiencies, osteoporosis, anaemia, fertility problems, neurological disturbances and 
malignancies. The only known treatment for CD is a lifelong adherence to gluten-free diet 
(GFD). 
In a Scandinavian genome wide scan, performed by our group and published in 2001, eight 
chromosomal regions apart from HLA showed nominal significance (p < 0,05), among them 
5q31-33. This region was previously suggested as a susceptibility region in other complex 
diseases: asthma, type 1 diabetes, rheumatoid arthritis and inflammatory bowel disease. 
The main goal of this study was to explore the region of 18cM on 5q31-33, identify genetic 
risk factors and evaluate their contribution to the development of CD. In 2003 a joint analysis 
of four independent genome scans was performed by the European Genetics Cluster on 
Coeliac Disease, a collaborative work between six European research groups, including our. 
Data from Italian, Finnish, UK and Swedish/Norwegian cohorts, a total of 442 families, was 
pooled together and analysed. The meta-analysis using pooled data confirmed 5q31-33 as 
the second most significant region after the HLA region. 
After the meta-analysis, we applied a fine mapping strategy on the 18cM region on 5q31-33. 
The most essential result of this study was the strengthened linkage signal on 5q31-33 
In 2006 we used the Illumina platform (GoldenGate assay technology) to perform an 
extensive screen of the region on 5q31-33. This study identified seven associated regions 
within 5q31-33 and a number of associated haplotypes but none of the association signals 
could explain the linkage peak observed in the families previously. 
In 2007 we performed a follow-up study of the association to the region comprising IL2/IL21 
genes on 4q27, reported in the first genome-wide association study (GWAS) in celiac cases 
and controls. We confirmed that the IL2/IL21 region is a susceptibility region in CD. 
Unfortunately, the first GWAS failed to identify specific genes predisposing to CD. The 
GWAS as well as our own fine mapping study pointed out the difficulties scientists face in 
searching for the causing variants in complex diseases. It appears that causing variants may 
be hard to detect with association analysis alone because of the strong linkage disequilibrium 
in associated regions. However, the GWAS detected a number of CD associated genomic 
regions which remain to be explored. 
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